Astrazeneca pause is a good thing: Stat News' Adam Feuerstein
Published Date: 9/9/2020
Source: CNBC Television
Astrazeneca has paused its Covid vaccine clinical trials after a volunteer participant had neurological symptoms. Adam Feuerstein, Stat News, joins CNBC's Meg Tirrell on 'Power Lunch' to discuss how he broke the story and what it could mean for Astrazeneca. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC For info on the best credit cards go to CNBC Select: https://www.cnbc.com/select/best-credit-cards/ #CNBC #CNBCTV